Literature DB >> 2670197

Mutagenic and cytogenetic studies of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

P R Padma1, A J Amonkar, S V Bhide.   

Abstract

The tobacco specific nitrosamines (TSNA) N'-nitrosonornicotine (NNN) and 4-(Methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK) were tested for mutagenic and clastogenic effects using a battery of short-term test systems. These test systems include the Ames test, micronucleus test (MNT), induction of chromosomal aberrations and sister chromatid exchange (SCEs). NNN and NNK were tested for their potency in inducing mutations in the Ames Salmonella/microsome assay and their clastogenic action were tested by the micronucleus inducing ability in vivo using Swiss mice. Studies on the induction of chromosomal aberrations and SCE exchange were carried out using human peripheral blood lymphocyte cultures. In the Ames test and MNT, NNN was positive but in comparisons with NNK, NNK was a more potent mutagen. Present studies clearly proves the genotoxic potential of both NNN and NNK and between the two NNK is more potent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670197     DOI: 10.1016/0304-3835(89)90127-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Development of ferret as a human lung cancer model by injecting 4-(Nmethyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

Authors:  Koichi Aizawa; Chun Liu; Sudipta Veeramachaneni; Kang-Quan Hu; Donald E Smith; Xiang-Dong Wang
Journal:  Lung Cancer       Date:  2013-12       Impact factor: 5.705

2.  Determinants of a genotoxic effect of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human diploid fibroblasts.

Authors:  C Pohlmann; F Koops; J Berg; O Holz; U Ehlert; H W Rüdiger
Journal:  Clin Investig       Date:  1992 Mar-Apr

3.  An analysis of the role of tobacco-specific nitrosamines in the carcinogenicity of tobacco smoke.

Authors:  Buddy G Brown; August J Borschke; David J Doolittle
Journal:  Nonlinearity Biol Toxicol Med       Date:  2003-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.